Telehealth has become an increasingly popular option for pregnant individuals seeking abortions in the United States, even in states where abortion is banned. By the end of 2024, a quarter of all abortions in the country were provided through telehealth services, with clinicians prescribing mifepristone and misoprostol online and mail-order pharmacies delivering the medications to patients.
Numerous studies have demonstrated that medication abortion through telehealth is just as safe and effective as in-person care, whether conducted through live video visits or text-based exchanges. However, the future of these services remains uncertain due to ongoing efforts by anti-abortion groups and legislators to restrict access.
Recently, a study published in JAMA provided a detailed breakdown of over 118,000 online prescriptions from Aid Access, one of the largest telemedicine abortion providers. The study revealed that telemedicine abortion rates were highest in Southern and Midwestern states with abortion bans, where 84% of prescriptions were issued. Access to telehealth abortion was particularly crucial in areas where individuals had to travel long distances to reach a clinic, and in counties with higher poverty levels.
The availability of telehealth abortion has significantly expanded access to care, especially in regions with limited or no in-person abortion services. This model of care has gained support due to increasing restrictions on traditional abortion clinics in many states.
Telehealth abortion offers numerous advantages, including convenience, affordability, and privacy. Patients can undergo the same screening process online as they would in person, ensuring their safety and well-being throughout the process.
Despite the proven safety and efficacy of medication abortion via telehealth, some lawmakers and anti-abortion organizations have raised concerns about its use. FDA Commissioner Marty Makary has faced questions about the safety of mifepristone and pledged to review its postmarket data, sparking further debate on the topic.
The ongoing legal battles surrounding telehealth abortion highlight the challenges of regulating access to care across state lines. While shield laws have provided some protection for providers like Maggie Carpenter, who has faced criminal charges for prescribing over state lines, there is still a significant mismatch between existing laws and the evolving landscape of telehealth services.
As telehealth abortion continues to grow in popularity and importance, it is essential to address the gaps in regulation and ensure that all individuals have access to safe and effective care. The findings from studies like Aid Access underscore the critical role that telemedicine plays in filling gaps in healthcare access and providing life-saving services to those in need.
